Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 77,115
  • Shares Outstanding, K 54,306
  • Annual Sales, $ 36,350 K
  • Annual Income, $ -28,510 K
  • 60-Month Beta 0.50
  • Price/Sales 1.98
  • Price/Cash Flow N/A
  • Price/Book 3.91
Trade CTSO with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -139.28%)
  • Historical Volatility 80.45%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,159.71% on 01/19/24
  • IV Low 0.00% on 09/19/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 47
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 595
  • Open Int (30-Day) 457

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.07
  • Number of Estimates 3
  • High Estimate -0.05
  • Low Estimate -0.09
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9300 +49.46%
on 09/11/24
1.5799 -12.02%
on 09/18/24
+0.3400 (+32.38%)
since 08/19/24
3-Month
0.7000 +98.57%
on 07/01/24
1.5799 -12.02%
on 09/18/24
+0.6370 (+84.59%)
since 06/18/24
52-Week
0.7000 +98.57%
on 07/01/24
2.1500 -35.35%
on 12/18/23
-0.6700 (-32.52%)
since 09/19/23

Most Recent Stories

More News
CytoSorbents: Q2 Earnings Snapshot

CytoSorbents: Q2 Earnings Snapshot

CTSO : 1.4211 (+0.08%)
CytoSorbents: Q1 Earnings Snapshot

CytoSorbents: Q1 Earnings Snapshot

CTSO : 1.4211 (+0.08%)
CytoSorbents: Q3 Earnings Snapshot

CytoSorbents: Q3 Earnings Snapshot

CTSO : 1.4211 (+0.08%)
CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...

CTSO : 1.4211 (+0.08%)
CytoSorbents: Q2 Earnings Snapshot

CytoSorbents: Q2 Earnings Snapshot

CTSO : 1.4211 (+0.08%)
CytoSorbents: Q1 Earnings Snapshot

CytoSorbents: Q1 Earnings Snapshot

CTSO : 1.4211 (+0.08%)
CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.4211 (+0.08%)
CytoSorbents to Report Fiscal 2022 Operating and Financial Results

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.4211 (+0.08%)
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.4211 (+0.08%)
CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.4211 (+0.08%)

Business Summary

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product...

See More

Key Turning Points

3rd Resistance Point 1.8065
2nd Resistance Point 1.6932
1st Resistance Point 1.5566
Last Price 1.4211
1st Support Level 1.3067
2nd Support Level 1.1934
3rd Support Level 1.0568

See More

52-Week High 2.1500
Fibonacci 61.8% 1.5961
Fibonacci 50% 1.4250
Last Price 1.4211
Fibonacci 38.2% 1.2539
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar